Dive into Imaging Science
Dive into Imaging Science
European Society for Molecular Imaging (ESMI)
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours
55 minutes Posted Sep 5, 2025 at 7:00 pm.
0:00
55:04
Download MP3
Show notes
GUEST: Rodney Hicks, MelbourneWelcome to Episode 17 of “Dive into Imaging Science”! 🎧 Tune in for a dynamic discussion on how NETTER-2 may reshape treatment strategies for neuroendocrine tumours, what it means for the wider field of theranostics, and where radioligand therapy is headed next. For our seventeenth edition, we are at the stunning Certosa di Pontignano in Tuscany – the home of TOPIM, which focussed this year on Theranostics. 🎯 Suitably, we discuss one of the most important r...